BioCentury
ARTICLE | Company News

Cytel, Epimmune infectious diseases, cancer news

June 21, 1999 7:00 AM UTC

CYTL will merge with its Epimmune majority-owned subsidiary and change its name to Epimmune Inc. (see BioCentury, April 5). After completion of the merger, expected on June 30, the company will trade ...